Jump Financial’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.04M	Sell	109,409 -801,521	-88%	-$6.22M	0.02%	902
2025 Q4	$7.11M	Sell	910,930 -13,846	-1%	-$100K	0.09%	286
2025 Q3	$7.02M	Sell	924,776 -422,336	-31%	-$3.52M	0.09%	306
2025 Q2	$12.1M	Buy	1,347,112 +1,198,263	+805%	+$11.2M	0.15%	200
2025 Q1	$1.12M	Sell	148,849 -114,489	-43%	-$923K	0.02%	783
2024 Q4	$1.98M	Sell	263,338 -8,401	-3%	-$63.8K	0.04%	515
2024 Q3	$2.07M	Buy	271,739 +71,539	+36%	+$544K	0.04%	502
2024 Q2	$1.24M	Buy	+200,200	New	+$1.1M	0.02%	723
2024 Q1	–	Sell	-128,771	Closed	-$771K	–	1900
2023 Q4	$771K	Sell	128,771 -276,142	-68%	-$1.6M	0.02%	841
2023 Q3	$2.87M	Buy	404,913 +319,037	+372%	+$2.29M	0.11%	251
2023 Q2	$605K	Sell	85,876 -227,665	-73%	-$1.83M	0.02%	936
2023 Q1	$2.61M	Buy	+313,541	New	+$3.02M	0.11%	299
2022 Q1	–	Sell	-33,300	Closed	-$461K	–	1552
2021 Q4	$461K	Buy	+33,300	New	+$441K	0.03%	689
2021 Q2	–	Sell	-19,105	Closed	-$194K	–	1084
2021 Q1	$194K	Buy	+19,105	New	+$197K	0.02%	766
2020 Q4	–	Sell	-191,283	Closed	-$657K	–	951
2020 Q3	$657K	Buy	+191,283	New	+$820K	0.13%	244